Primary hyperparathyroidism: Skeletal and non-skeletal effects, diagnosis and management

Maturitas

Volumn 70, Issue 3, 2011, Pages 246-255

  Pyram, Ronald ^a,b   Mahajan, Geeti ^a,b   Gliwa, Agnieszka ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cardiovascular diseases; Hypercalcemia; Hypercalciuria; Neuro psychiatric symptoms; Osteoporosis; Primary hyperparathyroidism PHTP

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; CALCITONIN; CALCIUM; CALCIUM SENSING RECEPTOR; CINACALCET; CREATININE; ESTROGEN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; OSTEOCALCIN; PAMIDRONIC ACID; PARATHYROID HORMONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TUMOR SUPPRESSOR PROTEIN;

ACUTE KIDNEY FAILURE; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CLINICAL FEATURE; COGNITION; CREATININE BLOOD LEVEL; DEPRESSION; GAIN OF FUNCTION MUTATION; HEART FUNCTION; HUMAN; HYPERCALCEMIA; HYPERTENSION; MINERAL METABOLISM; NEPHROLITHIASIS; NEUROPSYCHIATRY; NONHUMAN; OSTEOLYSIS; PARATHYROIDECTOMY; POPULATION; PRIMARY HYPERPARATHYROIDISM; QUALITY OF LIFE; RADIATION EXPOSURE; REVIEW; SURVIVAL; SYMPTOM; VASCULAR SMOOTH MUSCLE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

AGE FACTORS; BONE RESORPTION; CALCIUM; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, PRIMARY; KIDNEY CALCULI; PARATHYROID HORMONE; RENAL INSUFFICIENCY;

EID: 80054104578     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2011.07.021     Document Type: Review

References (120)

1. R.A. Wermers, S. Khosla, and E.J. Atkinson Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease J Bone Miner Res 21 2006 171 177 (Pubitemid 43023239)
2. G.R. Mundy, D.H. Cove, and R. Fisken Primary hyperparathyroidism: changes in the pattern of clinical presentation Lancet 1 1980 1317 1320 (Pubitemid 10063295)
3. L. Melton III The epidemiology of primary hyperparathyroidism in North America J Bone Miner Res 17 Suppl. 2 2002 N12 N17
4. D. Bartsch, C. Nies, and C. Hasse Clinical and surgical aspects of double adenoma in patients with primary hyperparathyroidism Br J Surg 82 1995 926 929
5. J.M. Ruda, C.S. Hollenbeak, and BC Stack Jr A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003 Otolaryngol Head Neck Surg 132 2005 359 372 (Pubitemid 40326684)
6. S.M. Huang, Q.Y. Duh, and J. Shaver Familial hyperparathyroidism without multiple endocrine neoplasia World J Surg 21 1997 22 28
7. D. Riccardi, and E.M. Brown Physiology and pathophysiology of the calcium-sensing receptor in the kidney Am J Physiol 298 2010 F485 F499
8. R. Kumar The regulation of parathyroid hormone secretion and synthesis J Am Soc Nephrol 22 2011 216 224
9. S.G. Fisher, and G.C. Wishart Hyperparathyroidism and hypocalcaemia Surgery (Oxford) 25 2007 487 491
10. L.M. McCann, and J. Beto Roles of calcium-sensing receptor and vitamin D receptor in the pathophysiology of secondary hyperparathyroidism J Ren Nutr 20 2010 141 150
11. M. Mannstadt Receptors for the PTH and PTHrP; their biological importance and functional properties Am J Physiol-Ren Physiol 277 1999 F665 F675
12. J. Tfelt-Hansen The calcium-sensing receptor in normal physiology and the pathophysiology: a review Crit Rev Clin Lab Sci 42 2005 35 70 (Pubitemid 41656709)
13. M. Kogawa The metabolism of 25-(OH) vitamin D3 by ostoeclasts and their precursors regulates the differentiation of osteoclasts J Steroid Biochem Mol Biol 121 2010 277 280
14. E.D. Hsi, L.R. Zukerberg, W.I. Yang, and A. Arnold Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study J Clin Endocrinol Metab 81 1996 1736 1739 (Pubitemid 26152455)
15. C.L. Rosenberg, H.G. Kim, T.B. Shows, H.M. Kronenberg, and A. Arnold Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors Oncogene 6 1991 449 453 (Pubitemid 21924102)
16. S. Hemmer, V.M. Wasenius, and C. Haglund Deletion of 11q23 cyclin D1 overexpression are frequent aberrations in parathyroid adenomas Am J Pathol 158 2001 1355 1362 (Pubitemid 32281299)
17. M.A. Vasef, R.K. Brynes, M. Sturm, C. Bromley, and R.A. Robinson Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasia: a paraffin immunohistochemical study Mod Pathol 12 1999 412 416 (Pubitemid 29203331)
18. Y. Imanishi, Y. Hosokawa, and K. Yoshimoto Primary hyperparathyroidism caused by parathyroid targeted overexpression of cyclin D1 in transgenic mice J Clin Invest 107 2001 1093 1102 (Pubitemid 32422906)
19. S.M. Mallya, J.J. Gallagher, and Y.K. Wild Abnormal parathyroid cell proliferation precedes biochemical abnormalities in a mouse model of primary hyperparathyroidism Mol Endocrinol 19 2005 2603 2609 (Pubitemid 41362672)
20. T. Carling, P. Correa, and O. Hessman Parathyroid MEN1 gene mutations in relation to clinical characteristics of non-familial primary hyperparathyroidism J Clin Endocrinol Metab 83 1998 2960 2963 (Pubitemid 28493806)
21. F. Farnebo, B.T. The, and S. Kytola Alterations of MEN1 gene in sporadic parathyroid tumors J Clin Endocrinol Metab 83 1998 2627 2630 (Pubitemid 28493751)
22. A. Falchetti, F. Marini, F. Giusti, L. Cavalli, and T. Cavalli Brandi ML DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes J Intern Med 266 2009 69 83
23. L.E. Tisell, G. Hansson, S. Lindberg, and I. Ragnhult Hyperparathyroidism in person treated with X-rays for tuberculous cervical adenitis Cancer 40 1977 846 854 (Pubitemid 8177909)
24. C.M. Beard, H. Heath III, W.M. O'Fallon, J.A. Anderson, J.D. Earle, and L.J. Melton III Therapeutic radiation and hyperparathyroidism. A case control study in Rochester Minn Arch Intern Med 149 1989 1887 1890 (Pubitemid 19200850)
25. S. Fujiwara, R. Sposto, and H. Ezaki Hyperparathyroidism among atomic bomb survivors in Hiroshima Radiat Res 130 1992 372 378
26. T. Rasmuson, and B. Travelin Risk of parathyroid adenomas in patients with thyrotoxicosis exposed to radioactive iodine Acta Oncol 45 2006 1059 1061 (Pubitemid 44808490)
27. S.J. Silverberg, and J.P. Bilezikian Evaluation and management of primary hyperparathyroidism Clin Endocrinol Metab 81 1996 2036 2040 (Pubitemid 26175923)
28. M. Taniguchi, M. Tanaka, T. Hamano, and S. Nakanishi Comparison between whole and intact parathyroid hormone assays Ther Apher Dial 15 Suppl 1 2011 42 49
29. S.J. Marx Hyperparathyroid and hypoparathyroid disorders N Engl J Med (Boston) 343 2000 1863 1875 (Pubitemid 32104134)
30. M.G. Mcgeown Effect of parathyroidectomy on the incidence of renal calculi Lancet 18 1961 586 587
31. C.L. Mollerup, P. Vestergaard, V.G. Frøkjaer, L. Mosekilde, P. Christiansen, and M. Blichert-Toft Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study BMJ 325 2002 807
32. Suh JM, Cronan JJ, Monchik JM. Primary hyperparathyroidism: is there an increased prevalence of renal stone disease? 2008;191:908-11.
33. L. Rejnmark, P. Vestergaard, and Mosekilde L Nephrolithiasis and renal calcifications in primary hyperparathyroidism J Clin Endocrinol Metab June (6) 2011 [Epub ahead of print]
34. J.P. Bilezikian, A.A. Khan, and J.T. Potts Jr. Third international workshop on the management of asymptomatic primary hyperthyroidism J Clin Endocrinol Metab 94 2009 335 433
35. J.P. Bilezikian, X. Meng, and Y. Shi Silverberg primary hyperparathyroidism in women: a tale of two cities - New York and Beijing J Fertil Womens Med 45 2000 1
36. E.M. Stein, D.W. Dempster, and J. Udesky Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism Bone 48 2011 557 561
37. G. Hedback, and A. Oden Death risk factor analysis in primary hyperparathyroidism Eur J Clin Invest 28 1998 1011 1018 (Pubitemid 29050136)
38. C.G. Øgard, G. Engholm, T.P. Almdal, and H. Vestergaard Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in Denmark World J Surg 28 2004 108 111 (Pubitemid 38095804)
39. I.L. Nilsson, L. Yin, E. Lundgren, J. Rastad, and A. Ekbom Clinical presentation of primary hyperparathyroidism in Europe - nationwide cohort analysis on mortality from nonmalignant causes J Bone Miner Res 17 Suppl. 2 2002 N68 N74
40. E. Lundgren, L. Lind, M. Palmér, S. Jakobsson, S. Ljunghall, and J. Rastad Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years Surgery 130 2001 978 985 (Pubitemid 34014563)
41. N. Yu, P.T. Donnan, and G.P. Leese A record linkage study of outcomes in patients with mild primary hyperparathyroidism: The Parathyroid Epidemiology and Audit Research Study (PEARS) Clin Endocrinol (Oxf) 75 2011 169 176
42. N. Yu, P.T. Donnan, R. Flynn, and M.J. Murphy Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS) Clin Endocrinol (Oxf) 73 2010 30 34
43. R.A. Wermers, S. Khosla, and E.J. Atkinson Survival after the diagnosis of hyperparathyroidism: a population-based study Am J Med 104 1998 115 122 (Pubitemid 28117404)
44. E. Hagstrom, E. Lundgren, and H. Lithell Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population based study over five years Clin Endocrinol 56 2002 253 260 (Pubitemid 34233964)
45. P. Farahnak, G. Lärfars, M. Sten-Linder, and I.L. Nilsson Mild primary hyperparathyroidism: Vitamin D deficiency and cardiovascular risk markers J Clin Endocrinol Metab 96 2011 2112 2118
46. M.D. Walker, J.B. Fleischer, and M.R. Di Tullio Cardiac structure and diastolic function in mild primary hyperparathyroidism J Clin Endocrinol Metab 95 2010 2172 2179
47. K. Dalberg, L.A. Brodin, A. Juhlin-Dannfelt, and L.O. Farnebo Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study Eur J Surg 162 1996 171 217
48. M.D. Walker, and S.J. Silverberg Cardiovascular aspects of primary hyperparathyroidism J Endocrinol Invest 31 2008 925 931
49. M.D. Walker, J. Fleischer, and T. Rundek Carotid vascular abnormalities in primary hyperparathyroidism J Clin Endocrinol Metab 94 2009 3849 3856
50. A. Ekmekci, N. Abaci, and N. Colak Ozbey Endothelial function and endothelial nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism J Endocrinol Invest 32 2009 611 616
51. C. Gennari, R. Nami, and S. Gonnelli Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin aldosterone systems Miner Electrolyte Metab 21 1995 77 81
52. T. Stefenelli, C. Abela, and H. Frank Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up J Clin Endocrinol Metab 82 1997 106 112 (Pubitemid 27021279)
53. A. Piovesan, N. Molineri, and F. Casasso Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy Clin Endocrinol 50 1999 321 328 (Pubitemid 29166711)
54. J. Bollerslev, T. Rosen, C.L. Mollerup, and J. Nordenstrom Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism J Clin Endocrinol Metab 94 2009 2255 2261
55. G. Barletta, M.L. De Feo, R. Del Bene, and C. Lazzeri Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism J Clin Endocrinol Metab 85 2000
56. A. Persson, J. Bollerslev, and T. Rosen Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism Clin Endocrinol 74 2011 174 180
57. P. Farahnak, M. Ring, K. Caidahl, L. Farnebo, and M.J. Eriksson Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy Eur J Endocrinol 163 2010 461 467
58. E.G. Almqvist, A.G. Bondeson, L. Bondeson, A. Nissborg, P. Smedgard, and S.E. Svensson Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy Surgery 132 2002 1126 1132 (Pubitemid 36026965)
59. K. Dalberg, L.A. Brodin, A. Juhlin-Dannfelt, and L.O. Farnebo Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study Eur J Surg 162 1996 171 176
60. H. Schiffl, and S.M. Lang Hypertension secondary to PHPT: cause or coincidence? Int J Endocrinol 2011 2011 974647
61. L. Lind, A. Hvarfner, and M.E. Palmér Hypertension in primary hyperparathyroidism in relation to histopathology J Surg 157 1991 457 459
62. R. Jorde, J. Svartberg, and J. Sundsfjord Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men J Hypertens 23 2005 1639 1644 (Pubitemid 41233422)
63. G. Zhao, E.S. Ford, C. Li, P.M. Kris-Etherton, T.D. Etherton, and L.S. Balluz Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults J Hypertens 2010 1821 1828
64. R. Wang, L. Wu, E. Karpinski, and P.K. Pang The effects of parathyroid hormone on L-type voltage-dependent calcium channel currents in vascular smooth muscle cells and ventricular myocytes are mediated by a cyclic AMP dependent mechanism FEBS Lett 282 1991 331 334
65. R. Schleiffer, C. Bergmann, F. Pernot, and A. Gairard Parathyroid hormone acute vascular effect is mediated by decreased Ca2+ uptake and enhanced cAMP level Mol Cell Endocrinol 67 1989 63 71 (Pubitemid 19262897)
66. P.K. Pang, M.C. Yang, and J.S. Sham Parathyroid hormone and calcium entry blockade in a vascular tissue J Life Sci 42 1988 1395 1400
67. M. Kosch, M. Hausberg, and K. Vormbrock Studies on flow-mediated vasodilation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism Am J Hypertens 13 2000 759 764 (Pubitemid 30604113)
68. I.L. Nilsson, J. Aberg, J. Rastad, and L. Lind Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy Surgery 129 1999 1049 1055
69. T. Neunteufl, R. Katzenschlager, and C. Abela Impairment of endothelium-independent vasodilation in patients with hypercalcemia Cardiovasc Res 40 1998 396 401 (Pubitemid 28506051)
70. L. Kovacs, M.I. Goth, I. Szabolcs, O. Dohán, A. Ferencz, and G. Szilágyi The effect of surgical treatment on secondary hyperaldosteronism and the relative hyperinsulinemia in primary hyperparathyroidism Eur J Endocrinol 138 1998 543 547 (Pubitemid 28238190)
71. G. Bernini, A. Moretti, S. Lonzi, C. Bendinelli, P. Miccoli, and A. Salvetti Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery Metabolism 48 1999 298 300 (Pubitemid 29115989)
72. P.D. Broulik, A. Brouliková, and S. Adámek Improvement of hypertension after parathyroidectomy of patients suffering from primary hyperparathyroidism Int J Endocrinol 2011 2011 309068
73. A. Heyliger, V. Tangpricha, C. Weber, and J. Sharma Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism Surgery 146 2009 1042 1047
74. C.A. Feldstein, M. Akopian, D. Pietrobelli, A. Olivieri, and D. Garrido Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism Clin Exp Hypertens 32 2010 154 158
75. C. Casella, G. Pata, E. Di Betta, and R. Nascimbeni Neurological and psychiatric disorders in primary hyperparathyroidism: the role of parathyroidectomy Ann Ital Chir 79 2008 157 161
76. J.L. Pasieka, and L.L. Parsons A retrospective analysis on the change in symptoms resulting from hyperparathyroidism following surgical intervention: allowing for the validation of a prospective surgical outcome study questionnaire World Congn Surg 1995 338 383
77. J.L. Pasieka, L.L. Parsons, and M.J. Demeure Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism J Surg 26 2002 942 949 (Pubitemid 36920291)
78. J.E. Ware Jr., and C.D. Sherbourne The MOS 35 item short form health survey (SF-36); conceptual framework and item selection Med Care 30 1992 473 548
79. R.E. Burney, K.R. Jones, B. Christy, and N.W. Thompson Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels Surgery 125 1999 608 614 (Pubitemid 29265002)
80. J.E. Ware, and C.D. Sherbourne The MOS 35 item short form health survey (SF-36); conceptual framework and item selection Med Care 30 30 1992 473 483
81. R. Mihai, and G.P. Sadler Pasieka's parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism World Surg 32 2008 807 814
82. G. Prager, A. Kalashek, and K. Kaczirek Parathyroidectomy improved concentration and retentiveness in patients with primary hyperparathyroidism Surgery 132 2002 930 936 (Pubitemid 36026938)
83. S.A. Roman, J.A. Sosa, and L. Mayes Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism Surgery 138 2005 1121 1129 (Pubitemid 41797353)
84. E.F. Eriksen, L. Mosekilde, and F. Melsen Bone remodeling and balance in primary hyperparathyroidism Bone 7 1986 213 221 (Pubitemid 17171903)
85. F. Melsen, and L. Mosekilde A tetracycline based evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism Acta Med Scand 204 1978 97 102 (Pubitemid 8406953)
86. S.A. Charon, C.M. Eduard, M. Arlot, and P.J. Meunier Effects of parathyroid hormone on remodeling of iliac trabecular bone packets in patients with primary hyperparathyroidism Clin Orthop Relat Res 162 1982 255 263 (Pubitemid 12180763)
87. S.J. Silverberg, E. Shane, and L. De La Cruz Skeletal disease in primary hyperparathyroidism J Bone Miner Res 4 1989 283 291 (Pubitemid 19161996)
88. D.W. Dempster, F. Cosman, M. Parisien, V. Shen, and R. Lindsay Anabolic actions of parathyroid hormone on bone Endocr Rev 14 1993 690 709 (Pubitemid 24016657)
89. A.B. Grey, M.C. Evans, J.P. Stapleton, and I.R. Reid Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism Ann Inter Med 211 1994 745 749
90. C.Y. Guo, W.E. Thoma, A.W. Al Dehaimi, A.M. Assiri, and R. Eastell Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism J Clin Endocrinol Metab 81 1996 3487 3491 (Pubitemid 26339904)
91. M.T. McDermott, J.J. Perloff, and G.S. Kidd Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy J Bone Miner Res 9 1994 509 514 (Pubitemid 24090333)
92. S.J. Silverberg, E. Shane, T.P. Jacobs, E. Siris, and J.P. Bilezikian A 10-year prospective study of primary hyperparathyroidism with or without parathyroidectomy NEJM 341 1999 1249 1255 (Pubitemid 29489739)
93. Q. Chen, H. Kaji, and M.-F. Iu Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects J Clin Endocrinol Metab 88 2003 4655 4658 (Pubitemid 37357507)
94. L.H. VanderWalde Effect of bone mineral density and parathyroidectomy on fracture risk in primary hyperparathyroidism World J Surg 33 2009 406 411
95. D.S. Rao, E.A. Wallace, and R.F. Antonelli Forearm bone density in primary hyperparathyroidism: long term follow-up with and without parathyroidectomy Clin Endocrinol (Oxf) 58 2003 348 354 (Pubitemid 36308124)
96. P. Vestergaard Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism Br Med J 321 2000 598 602
97. M.R. Rubin, J.P. Bilezikian, and D.J. McMahon The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years J Clin Endocrinol Metab 93 2008 3462 3470
98. E. Ishimura, T. Miki, and H. Koyama Effect of aminohydroxypropylidene diphosphonate on the bone metabolism of patients with parathyroid adenoma Horm Metab Res 25 1993 493 497 (Pubitemid 23274575)
99. P. Ammann, C. Herter-Clavel, A. Lubrano, and R. Rizzoli A single bisphosphonate infusion is associated with improved functional capacity in elderly subjects with primary hyperparathyroidism Aging Clin Exp Res 15 2003 500 504 (Pubitemid 38180789)
100. M. Rossini, D. Gatti, G. Isaia, L. Sartori, V. Braga, and S. Adami Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism J Bone Miner Res 16 2001 113 119 (Pubitemid 32046195)
101. C.R. Parker, P.J. Blackwell, K.J. Fairbairn, and D.J. Hosking Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study J Clin Endocrinol Metab 87 2002 4482 4489 (Pubitemid 35247029)
102. C.C. Chow, W.B. Chan, and J.K. Li Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism J Clin Endocrinol Metab 88 2003 581 587 (Pubitemid 36207794)
103. J.M. Hershman, S. Hassani, G.D. Braunstein, F. Geola, A. Brickman, and M.J. Siebel Bisphosphonate therapy in primary hyperparathyroidism J Bone Miner Res 18 2003 1889
104. M. Peacock, M.A. Bolognese, and M. Borofsky Treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study J Clin Endocrinol Metab 94 2009 4860 4867
105. M. Peacock, J.P. Bilezikian, P.S. Klassen, M.D. Guo, S.A. Turner, and D. Shoback Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism J Clin Endocrinol Metab 90 2005 135 141 (Pubitemid 40116646)
106. E. Ambrogini Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective randomized clinical trial J Clin Endocrinol Metab 92 2007 3114 3121 (Pubitemid 47236379)
107. M. Peacock, J.P. Bilezikian, and M.A. Bolognese Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity J Clin Endocrinol Metab 96 2011 E9 E18
108. J.P. Bilezikian, J.T. Potts Jr., and -H. Fuleihan Gel Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century J Clin Endocrinol Metab 87 2002 5353 5361 (Pubitemid 36034328)
109. B. Wu, P.I. Haigh, and R. Hwang Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism J Clin Endocrinol Metab 95 2010 4324 4330
110. P. Boudou, F. Ibrahim, and C. Cormier A very high incidence of low 25 hydroxyvitamin D serum concentration in a French population of patients with primary hyperparathyroidism J Endocrinol Invest 29 2006 511 515 (Pubitemid 44164892)
111. P. Lips, T. Duong, and A. Oleksik A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial J Clin Endocrinol Metab 86 2001 1212 1221 (Pubitemid 32323007)
112. Z.A. Stewart, A. Blackford, and H. Somervell 25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy Surgery 138 2005 1018 1025
113. V. Kantorovich, M.A. Gacad, and L.L. Seeger Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism J Clin Endocrinol Metab 85 2000 3541 3543
114. A. Grey, J. Lucas, and A. Horne Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency J Clin Endocrinol Metab 90 2005 2122 2126 (Pubitemid 40586249)
115. J.R. Tucci Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D Eur J Endocrinol 161 2009 189 193
116. M.L. Isidro, and B. Ruano Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency Endocrine 36 2009 305 310
117. E.G. Grubbs, S. Rafeeq, and C. Jimenez Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? Surgery 144 2008 852 858
118. E.M. Brown Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid Nature 366 1993 575 580 (Pubitemid 24035999)
119. G.N. Kent, C.I. Bhagat, and P. GarciaWebb Tubular maximum for calcium reabsorption: lack of diagnostic usefulness in primary hyperparathyroidism and familial hypocalciuric hypercalcaemia Clin Chim Acta 166 2-3 1987 Jul 15 155 161 (Pubitemid 17100855)
120. N. Yu, G.P. Leese, D. Smith, and P.T. Donnan The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and Audit Research Study QJM 104 2011 513 521